CLASP II TR Pivotal, Study No. 2019-07
Research payments
$21,717,124
Through program year 2025, $21,717,124 in research payments was reported against CLASP II TR Pivotal, Study No. 2019-07, across 1,983 payments, paid by Edwards Lifesciences Corporation.
- Paid by
- Edwards Lifesciences Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $3,809,395 | 483 |
| 2024 | Research | $6,900,831 | 490 |
| 2023 | Research | $4,711,267 | 409 |
| 2022 | Research | $3,457,609 | 341 |
| 2021 | Research | $2,117,406 | 178 |
| 2020 | Research | $708,578 | 81 |
| 2019 | Research | $12,038 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Alan Zajarias Saint Louis, MO Named on 61 payments
- Mohamed Azeem Latib Bronx, NY Named on 44 payments
- Nirat Beohar Miami Beach, FL Named on 35 payments
- Mubashir Mumtaz Harrisburg, PA Named on 35 payments
- Steve Xydas Morristown, NJ Named on 35 payments
- Sammy Elmariah San Francisco, CA Named on 34 payments
- Molly Szerlip Plano, TX Named on 32 payments
- Robert Kipperman Oklahoma City, OK Named on 31 payments
- Adnan Chhatriwalla Kansas City, MO Named on 30 payments
- Mark Kozak Hershey, PA Named on 29 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.